Matthew Harlow is a Scientist II at Civetta Therapeutics. Matthew received their PHD from Vanderbilt University Medical Center in 2011 and has been a Postdoctoral Fellow at Dana-Farber Cancer Institute since 2017.
Matthew Harlow has a Doctor of Philosophy - PhD in Oncology and Cancer Biology from Vanderbilt University School of Medicine. Matthew also has a Bachelor of Science (B.S.) in Biology, General from University of North Carolina at Chapel Hill.
They work with Jessica Weatherbee - Scientist II, Todd McHugh - Research Associate I, Biology, and Cecile Rouleau - Senior Scientist, Biology. Matthew Harlow reports to Tom Chen, Associate Director, Biology.
Current role